FURMONERTINIB

Clinical trials for FURMONERTINIB explained in plain language.

Never miss a new study

Get alerted when new FURMONERTINIB trials appear

Sign up with your email to follow new studies for FURMONERTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New dosing strategy aims to tackle lung cancer brain spread

Disease control Recruiting now

This study is for people with a specific type of advanced lung cancer (EGFR-mutant NSCLC) that has spread to the lining of the brain (leptomeningeal metastasis). It tests whether taking a higher dose of the drug furmonertinib every other day works better and is safe compared to t…

Matched conditions: FURMONERTINIB

Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control

Last updated May 07, 2026 18:39 UTC

FURMONERTINIB

Get alerted when new FURMONERTINIB trials appear

New dosing strategy aims to tackle lung cancer brain spread